Asanpharm is a company dedicated to improving health and well-being through innovative diagnostic solutions. The company focuses on developing and providing high-quality in vitro diagnostic (IVD) products and related technologies.
Its product range includes IVD reagents such as rapid diagnostic tests (RDT), qPCR-based reagents, culture media, and specimen transport media. These products support testing for various diseases, including infectious conditions like dengue, syphilis, influenza, and COVID-19.
The company emphasizes research and development, operating an R&D center aimed at advancing diagnostic technologies. Asanpharm also offers IVD readers and analytical equipment to complement its diagnostic offerings.
With a global outlook, Asanpharm provides sales materials and support internationally, aiming to contribute to healthier lives through reliable and accessible diagnostic tools.